Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Off-Label Use “Predictions” May Be Scrutinized, Prosecutor Sheehan Says

Executive Summary

Companies may include predictions of off-label use in their business plans but should be careful not to cross the line into encouraging off-label promotion, Philadelphia Associate U.S. Attorney James Sheehan suggested at a Food and Drug Law Institute advertising conference in Washington, D.C

You may also be interested in...



Sheehan joins Spitzer

James Sheehan is nominated to serve as New York State Medicaid Inspector General, Governor Eliot Spitzer announces April 11, where he will oversee the fraud and abuse enforcement activities of New York's $50 billion Medicaid program. Sheehan, who currently serves as the Associate U.S. Attorney for Civil Programs in the Eastern District of Pennsylvania, has been involved in a number of pharmaceutical industry-related cases (1"The Pink Sheet" Sept. 20, 2006, p. 6). As New York attorney general, Spitzer was similarly active in cases involving the pharmaceutical industry. [Editor's Note: "The Pink Sheet" now publishes a monthly round-up employment changes, professional awards, and other news about people in the pharma industry. Please submit announcements to k.phelps@elsevier.com]....

Sheehan joins Spitzer

James Sheehan is nominated to serve as New York State Medicaid Inspector General, Governor Eliot Spitzer announces April 11, where he will oversee the fraud and abuse enforcement activities of New York's $50 billion Medicaid program. Sheehan, who currently serves as the Associate U.S. Attorney for Civil Programs in the Eastern District of Pennsylvania, has been involved in a number of pharmaceutical industry-related cases (1"The Pink Sheet" Sept. 20, 2006, p. 6). As New York attorney general, Spitzer was similarly active in cases involving the pharmaceutical industry. [Editor's Note: "The Pink Sheet" now publishes a monthly round-up employment changes, professional awards, and other news about people in the pharma industry. Please submit announcements to k.phelps@elsevier.com]....

Genzyme Closes Ilex Deal After FTC Orders “Creative” Campath Divestiture

Genzyme will be precluded from any involvement with Campath (alemtuzumab) in the organ transplant rejection therapy market under a consent order with the Federal Trade Commission allowing the company to complete the acquisition of Ilex

Related Content

Topics

UsernamePublicRestriction

Register

SC081785

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel